- Home
- RYAN vs CAI Comparison
RYAN vs CAI Comparison
Compare RYAN & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYAN
- CAI
- Stock Information
- Founded
- RYAN 2010
- CAI 2008
- Country
- RYAN United States
- CAI United States
- Employees
- RYAN N/A
- CAI N/A
- Industry
- RYAN Specialty Insurers
- CAI Medical Specialities
- Sector
- RYAN Finance
- CAI Health Care
- Exchange
- RYAN Nasdaq
- CAI Nasdaq
- Market Cap
- RYAN 7.4B
- CAI 8.5B
- IPO Year
- RYAN 2021
- CAI 2025
- Fundamental
- Price
- RYAN $58.13
- CAI $25.42
- Analyst Decision
- RYAN Buy
- CAI Strong Buy
- Analyst Count
- RYAN 12
- CAI 6
- Target Price
- RYAN $68.60
- CAI $35.50
- AVG Volume (30 Days)
- RYAN 1.8M
- CAI 1.0M
- Earning Date
- RYAN 10-30-2025
- CAI 11-05-2025
- Dividend Yield
- RYAN 0.83%
- CAI N/A
- EPS Growth
- RYAN N/A
- CAI N/A
- EPS
- RYAN N/A
- CAI N/A
- Revenue
- RYAN $2,905,944,000.00
- CAI $649,062,000.00
- Revenue This Year
- RYAN $27.58
- CAI $64.66
- Revenue Next Year
- RYAN $16.69
- CAI $45.81
- P/E Ratio
- RYAN $217.22
- CAI N/A
- Revenue Growth
- RYAN 24.88
- CAI 112.02
- 52 Week Low
- RYAN $50.08
- CAI $22.86
- 52 Week High
- RYAN $77.16
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- RYAN 63.11
- CAI N/A
- Support Level
- RYAN $52.77
- CAI N/A
- Resistance Level
- RYAN $55.11
- CAI N/A
- Average True Range (ATR)
- RYAN 1.56
- CAI 0.00
- MACD
- RYAN 0.63
- CAI 0.00
- Stochastic Oscillator
- RYAN 90.64
- CAI 0.00
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.